Clinical Trial

Laparoscopic vs. Open Distal Gastrectomy After Neoadjuvant Chemotherapy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 8, 2020 (before its estimated December 2023 completion). Its status may not reflect the trial's current state.
Summary
The study was designed as single-country, multi-center, open-labelled, randomized (1:1), phase II trial. 238 patients with medically and technically operable advanced gastric adenocarcinoma in middle or distal 1/3 of stomach are enrolled and randomly assigned to laparoscopic gastrectomy group and open gastrectomy group. 4 cycles of mFLOT chemotherapy will be conducted before and after gastrectomy. The primary objective of this study is comparison of D2 lymph node dissection compliance rate between open surgery group and laparoscopic surgery group after neoadjuvant chemotherapy.
Trial Details
NCT Number NCT04658589
Lead Sponsor Chonnam National University Hospital
Conditions Stomach Neoplasm
Enrollment 238 participants
Start Date 2021-01
Primary Completion 2023-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2020-12-08